人类甲型肺炎病毒在儿童住院治疗:一个追溯审计
R A Hibbert1,2, D R Cheng1,2, Alissa McMinn2
1Department of General Medicine, The Royal Children's Hospital, Parkville, Australia.
Journal of paediatrics and child health
|November 17, 2025
概括
人类甲肺病毒 (hMPV) 的住院治疗在幼儿中很常见. 两岁以下的儿童和患有并发症的儿童面临更高的严重疾病和ICU入院风险,突出了预防策略的必要性.
科学领域:
- 儿童传染病 儿童传染病
- 病毒学 病毒学
- 公共卫生 公共卫生
背景情况:
- 人类甲肺病毒 (hMPV) 是儿童住院治疗的重要原因之一.
- 目前,没有获得许可的疫苗或针对hMPV的特定抗病毒治疗方法.
- 了解hMPV的临床影响和风险因素对于开发干预措施至关重要.
研究的目的:
- 描述儿童hMPV住院治疗的临床特征和季节性.
- 为了确定患有严重hMPV疾病的风险较高的儿童.
- 为制定预防策略提供信息.
主要方法:
- 儿童患者 (0-18岁) 的回顾性审计,hMPV PCR测试呈阳性.
- 从2016年5月到2023年12月在四级儿童医院收集的数据.
- 分析包括临床和流行病学数据.
主要成果:
- 包括1296名儿童;50%的儿童年龄在2岁以下.
- 季节性显示出典型的冬季上升,由COVID-19中断,随后反弹.
- 患有并发症的儿童 (41.2%) 住院时间更长,ICU入院率更高 (16.1%对6.7%).
- 在30天内发生了三起死亡,所有这些都是患有潜在恶性瘤的儿童.
结论:
- hMPV显著影响儿科住院,特别是在婴儿和患有并发病的人群中.
- 年龄较小的儿童 (<2岁) 和患有并发症的儿童面临严重后果的风险增加,包括ICU入院.
- 迫切需要有效的预防策略来预防儿童hMPV感染.
相关概念视频
01:30Pneumonia I: Introduction
712
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
712
01:28Pneumonia IV: Management
740
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
740
01:30Pneumonia III: Complications and Assessment
768
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
768
01:30Pneumonia V: Nursing management and Prevention
3.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
01:29Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
01:21Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K